StemCells, Inc. · Palo Alto, CA United States (NASDAQ: STEM)
Key StemCells, Inc. Financials
| Company Type | Public -(NASDAQ: STEM) Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2010 Sales (mil.) | $1.4 |
| 2010 Employees | 74 |
StemCells, Inc. Income Statement
| Dec 10 | Dec 09 | Dec 08 | |
| Revenue | 1.4 | 1.0 | 0.2 |
| Cost of Goods Sold | 0.2 | 0.3 | 0.0 |
| Gross Profit | 1.3 | 0.7 | 0.2 |
| Gross Profit Margin | 88.2% | 73.7% | 100% |
| SG&A Expense | 9.4 | 9.5 | 8.3 |
| Depreciation & Amortization | 1.5 | 1.7 | 1.2 |
| Operating Income | (29.4) | (29.4) | (26.7) |
| Operating Margin | -2057.5% | -2958.9% | -11538.4% |
| Nonoperating Income | 4.2 | 2.4 | (3.0) |
| Nonoperating Expenses | (0.1) | (0.0) | 0.7 |
| Income Before Taxes | -- | -- | -- |
| Income Taxes | -- | -- | -- |
| Net Income After Taxes | 0.0 | 0.0 | 0.0 |
| Continuing Operations | (25.2) | (27.0) | (29.1) |
| Discontinued Operations | -- | -- | -- |
| Total Operations | (25.2) | (27.0) | (29.1) |
| Total Net Income | (25.2) | (27.0) | (29.1) |
| Net Profit Margin | -1769% | -2722% | -12552% |
| Diluted EPS from Total Net Income | (2.00) | (2.50) | (3.50) |
| Dividends per Share | -- | -- | -- |
All amounts in millions of US Dollars except per share amounts.
StemCells, Inc. Balance Sheet
| Assets | Dec 10 | Dec 09 | Dec 08 |
| Current Assets | |||
| Cash | 19.7 | 38.6 | 30.0 |
| Net Receivables | 0.3 | 0.8 | 0.5 |
| Inventories | -- | -- | -- |
| Other Current Assets | 1.2 | 0.8 | 4.8 |
| Total Current Assets | 21.2 | 40.1 | 35.3 |
| Net Fixed Assets | 2.6 | 2.9 | 3.2 |
| Other Noncurrent Assets | 6.8 | 8.2 | 2.7 |
| Total Assets | 30.6 | 51.2 | 41.2 |
| Liabilities | Dec 10 | Dec 09 | Dec 08 |
| Current Liabilities | |||
| Accounts Payable | 1.1 | 0.9 | 1.1 |
| Short-Term Debt | 0.2 | 0.2 | 0.2 |
| Other Current Liabilities | 4.2 | 5.4 | 4.1 |
| Total Current Liabilities | 5.5 | 6.5 | 5.3 |
| Long-Term Debt | 0.5 | 0.8 | 0.9 |
| Other Noncurrent Liabilities | 9.1 | 13.4 | 13.2 |
| Total Liabilities | 15.1 | 20.7 | 19.4 |
| Shareholder's Equity | |||
| Preferred Stock Equity | -- | -- | -- |
| Common Stock Equity | 15.5 | 30.5 | 21.8 |
| Total Equity | 15.5 | 30.5 | 21.8 |
| Shares Outstanding (thou.) | 12,731.3 | 11,835.0 | 8,114.5 |
All amounts in millions of US Dollars except per share amounts.
StemCells, Inc. Cash Flow Statement
| Dec 10 | Dec 09 | Dec 08 | |
| Net Operating Cash Flow | (25) | (25) | (23) |
| Net Investing Cash Flow | (0.9) | 3.7 | 24.2 |
| Net Financing Cash Flow | 6.6 | 29.8 | 18.8 |
| Net Change in Cash | (18.9) | 8.8 | 20.3 |
| Depreciation & Amortization | 1.5 | 1.7 | 1.2 |
| Capital Expenditures | (0.9) | (0.7) | (0.3) |
| Cash Dividends Paid |
All amounts in millions of US Dollars except per share amounts.